Observational Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Aug 14, 2025; 31(30): 109256
Published online Aug 14, 2025. doi: 10.3748/wjg.v31.i30.109256
Table 4 Features among those with and without portal hypertension (excluding smokers and beta blocker users)
Baseline characteristics
NCPH (n = 7)
Preclinical NCPH (n = 9)
P value1
Age (years)51 (42-63)46 (39-57)0.6
Male gender, n (%)4 (57)5 (56)0.8
Body mass index (kg/m2)25.8 (23.3-31.6)25.1 (18.6-25.7)0.09
Heart rate (bpm)70 (67-80)70 (65-75)0.2
Systolic blood pressure (mmHg)116 (113-128)124 (114-129)0.7
Diastolic blood pressure (mmHg)67 (55-71)68 (68-69)0.5
Oxygen saturation (%)96 (96-98)97 (96-97)0.7
Sodium (mEq/L)139 (138-140)139 (138-139)0.9
Creatinine (mg/dL)0.8 (0.7-0.8)0.8 (0.7-1.0)0.7
Albumin (g/dL)3.9 (3.8-3.9)4.1 (3.5-4.2)0.9
Haemoglobin (g/dL)12.7 (11.9-14.1)13 (12.8-15.7)0.3
C-reactive protein (mg/dL)1.2 (0.6-3.9)1.5 (1.0-2.6)0.4
Left ventricular ejection fraction (%)60 (59-62)62 (62-65)0.1
Cardiac output (L/min)5.6 (5.2-7.8)5.2 (4.4-6.0)0.3
Cardiac index (L/min/m2)2.9 (2.7-3.8)2.8 (2.7-3.0)0.5
LV diastolic volume (mL)146 (133-164)97 (89-121)0.02
LV diastolic volume index (mL/m2)69 (64-86)57 (48-59)0.04
LV mass index (gm/m2)84.9 (80.5-98.3)68.4 (64.1-86.5)0.3
LV global longitudinal strain (%)-22.7 (-24.4--19.0)-21.6 (-22.3--19.9)0.9
RV free wall strain (%)-24.6 (-26.9--23.5)-25.9 (-28.9--24.3)0.6
RVSP (mmHg)26 (24-38)27 (25-30)0.3
LA volume (ml)80 (73-85)46 (34-59)0.03
LA volume index (mL/m2)37 (35-44)23 (22-29)0.04
RA volume (mL)57 (52-64)28 (26-43)0.09
RA volume index (mL/m2)26 (26-30)16 (13-20)0.1
Septal MV E/e’ 10.0 (8.1-11.7)7.4 (6.5-8.8)0.1
Lateral MV E/e’ 7.8 (6.5-9.8)4.9 (4.5-6.9)0.1
Septal e’ (cm/s)9 (8-11)11 (10-11)0.4
Lateral e’ (cm/s)12 (12-15)15 (10-15)0.8
TAPSE (mm)25 (22-26)24 (23-25)0.9
Mitral E to A ratio1.2 (0.8-1.2)1.4 (1.1-1.5)0.9
IVC diameter (mm)23.0 (16.8-30.8)20.0 (12.0-21.0)0.1